Navigation Links
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
Date:11/19/2007

forward-looking information or statements.

For Bristol-Myers Squibb

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006, in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

For full Prescribing Information including boxed WARNING regarding Use in Pregnancy, please visit: http://www.AVAPROAVALIDE.com or http://www.bms.com.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
5. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
6. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and LONDON ... leading distributor of market intelligence, MarketResearch.com is pleased to ... IQ4I Research and Consultancy focusing on the active pharmaceutical ... IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Global Market – Forecast to 2020 , ...
(Date:11/26/2014)... NEW YORK , Nov. 25, 2014 /PRNewswire/ ... with Covidien has been widely discussed in ... but it,s also creating a stronger leading player ... according to Kalorama Information.  The healthcare market research ... monitoring systems will feature a diverse set of ...
(Date:11/26/2014)... , Nov. 25, 2014  Breckenridge Pharmaceutical, Inc. ... multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) ... which Breckenridge and Pii expect to develop and ... the agreement, Pii will develop, manufacture and supply ... the products under its own label.  The drugs, ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... shows one in five sisters of a primary ... ROCHESTER, Minn., Sept. 10 Mayo Clinic,researchers ... of patients with primary biliary cirrhosis (PBC) are,more ... in their blood. Armed with,this new information, physicians ...
... The following letter is,being released by CEL-SCI CORPORATION (Amex: ... Shareholders: The past 12 months have been the ... Drug Administration (FDA) granted us the go-,ahead for a ... drug,Multikine(R) and also granted Multikine Orphan drug designation. Following,the ...
Cached Medicine Technology:New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for elder ... the adult demographic education and access to computer ... rough seas of applying for Medicaid. Part of this ... of Medicaid eligibility and proper planning, while also helping ... this coverage. , Senior Planning Services has made ...
(Date:11/26/2014)... IL (PRWEB) November 26, 2014 ... communication management solutions, has been award the ... Magazine. , This award comes as a great ... capabilities within the Lync ecosystem. Specifically, ISI offers ... all modes of Lync communication, including voice, video, ...
(Date:11/26/2014)... Albany, NY (PRWEB) November 26, 2014 ... industry research requirements or email the details on sales(at)researchmoz(dot)us ... "Worldwide diabetes and drug discovery market 2014" with deep ... Diabetes is the result of high blood sugar. The ... is directly linked to the growing number of diabetics ...
(Date:11/26/2014)... 2014 Bunion Bootie, the newest and ... an early celebration of the early holiday shopping season. ... at the promotional price of $29.95 each (normally $33.95 ... to any automatic discounts applied when buying more than ... for complete details. It’s simple: purchasing more Bunion ...
(Date:11/26/2014)... 2014 Louisiana Back Institute, leaders ... in minimally invasive spine surgery, announces today the ... rapidly growing provider network of orthopedic spine surgeons ... with the network’s continuing success providing the most ... residents who are suffering from orthopedic spine conditions ...
Breaking Medicine News(10 mins):Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2
... The most poisonous substance on Earth already used medically ... wrinkles could be re-engineered for an expanded role in ... other diseases, scientists are reporting. Their study appears in ACS, ... that toxins, or poisons, produced by Clostridium botulinum ...
... HealthDay Reporter , TUESDAY, Nov. 29 (HealthDay ... hip replacement devices appear to work the same, a ... seem to be no more effective than older implants ... said. "Metal-on-metal and ceramic-on-ceramic hip implants might not ...
... Findings on coronary CT angiography (CTA), a noninvasive test to ... for men and women, according to a study presented today ... artery disease (CAD) is a narrowing of the blood vessels ... caused by a build-up of fat and other substances that ...
... TUESDAY, Nov. 29 (HealthDay News) -- Men are less willing ... have higher cancer death rates, a new study shows. ... New York City, Baltimore, and San Juan, Puerto Rico, who ... participants were aged 30 to 59, and 35 percent of ...
... Gass, MD, chief of surgery at Women & Infants Hospital ... Health Center in the hospital,s Program in Women,s Oncology, recently ... surgeon Krishna B. Clough, MD, medical director of the Paris ... novel surgical technique available to breast cancer patients through Women ...
... HOUSTON -- Combination treatment with everolimus, an inhibitor ... has shown to improve progression-free survival for patients ... carcinoid syndrome, according to researchers at The University ... of the international, randomized, placebo-controlled Phase III study ...
Cached Medicine News:Health News:New Hip Implants No Better Than Older Ones, Study Finds 2Health News:New Hip Implants No Better Than Older Ones, Study Finds 3Health News:Heart attack risk differs between men and women 2Health News:Men More Likely to Skip Cancer Screenings: Study 2Health News:Surgeon studies with world-renowned oncoplastic pioneer 2Health News:Surgeon studies with world-renowned oncoplastic pioneer 3Health News:Everolimus prolongs progression-free survival for patients with neuroendocrine tumors 2Health News:Everolimus prolongs progression-free survival for patients with neuroendocrine tumors 3
... Pulsavac Wound Debridement System ... for pulsatile irrigation,and debridement. ... range of fluid pressure ... lavage to a penetrating ...
... Amsco 3085 SP Surgical Table provides state-of-the-art ... now be networked with the HERMES Control ... Stryker Endoscopy) to allow the surgeon direct ... surgeon uses either simple voice commands or ...
... The ASC 2000 is ... care table, meeting good manufacturing ... regulatory requirements. It provides electro-hydraulic ... accessories for all ambulatory surgical ...
... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
Medicine Products: